Potential of nano-antioxidants and nanomedicine for recovery from neurological disorders linked to long COVID syndrome

T Akanchise, A Angelova - Antioxidants, 2023 - mdpi.com
Long-term neurological complications, persisting in patients who cannot fully recover
several months after severe SARS-CoV-2 coronavirus infection, are referred to as …

Use of antioxidants for the neuro-therapeutic management of COVID-19

N Cardenas-Rodriguez, C Bandala, A Vanoye-Carlo… - Antioxidants, 2021 - mdpi.com
Coronavirus Disease 2019 (COVID-19), caused by Severe Acute Respiratory Syndrome
Coronavirus 2 (SARS-CoV-2), is an emergent infectious disease that has caused millions of …

Neurological damages in COVID‐19 patients: Mechanisms and preventive interventions

S Sarkar, S Karmakar, M Basu, P Ghosh… - MedComm, 2023 - Wiley Online Library
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), a novel coronavirus,
causes coronavirus disease 2019 (COVID‐19) which led to neurological damage and …

Pathophysiological clues to how the emergent SARS-CoV-2 can potentially increase the susceptibility to neurodegeneration

M Dolatshahi, M Sabahi, MH Aarabi - Molecular neurobiology, 2021 - Springer
Along with emergence of the novel severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) in late 2019, a myriad of neurologic symptoms, associated with structural brain …

Systematic review of the common pathophysiological mechanisms in COVID-19 and neurodegeneration: the role of bioactive compounds and natural antioxidants

K Choe, HY Park, M Ikram, HJ Lee, TJ Park, R Ullah… - Cells, 2022 - mdpi.com
The novel coronavirus (2019-nCoVCOVID-19) belongs to the Beta coronavirus family, which
contains MERS-CoV (Middle East respiratory syndrome coronavirus) and SARS-CoV …

SARS-CoV-2 getting into the brain; neurological phenotype of COVID-19, and management by nano-biotechnology

M Kujawska, E Mostafavi, A Kaushik - Neural Regeneration …, 2023 - journals.lww.com
Human coronavirus infection getting into the brain: By February 2022, the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, causing the coronavirus …

[HTML][HTML] Oxidative stress and COVID-19-associated neuronal dysfunction: mechanisms and therapeutic implications: SARS-CoV-2 (COVID-19)-mediated oxidative …

DR Bowen, S Pathak, RM Nadar… - Acta Biochimica et …, 2023 - ncbi.nlm.nih.gov
Severe acute respiratory syndrome (SARS)-CoV-2 virus causes novel coronavirus disease
2019 (COVID-19), and there is a possible role for oxidative stress in the pathophysiology of …

[HTML][HTML] Possible immunity, inflammation, and oxidative stress mechanisms of Alzheimer's disease in COVID-19 patients

H Wang, R Qin, J Zhang, Y Chen - Clinical Neurology and …, 2021 - ncbi.nlm.nih.gov
We have read with great interest the paper from Alomari et al.[1] about the “COVID-19 and
the Central Nervous System”. With the prevalence of Severe Acute Respiratory Syndrome …

Exploring the Paradox of COVID‐19 in Neurological Complications with Emphasis on Parkinson's and Alzheimer's Disease

SN Rai, N Tiwari, P Singh, AK Singh… - Oxidative medicine …, 2022 - Wiley Online Library
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is a human coronavirus
(HCoV) that has created a pandemic situation worldwide as COVID‐19. This virus can …

[HTML][HTML] Long-term respiratory and neurological sequelae of COVID-19

F Wang, RM Kream, GB Stefano - Medical science monitor …, 2020 - ncbi.nlm.nih.gov
Since the initial reports of coronavirus disease 2019 (COVID-19) in China in late 2019,
infections from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have …